Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole and Aspirin Polyp Prevention Study
NCT06378398Phase 1Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jun 2024
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of omeprazole and aspirin in Colorectal neoplasia, sponsored by University of Michigan Rogel Cancer Center. Primary endpoint: Identification of biomarkers for omeprazole/aspirin combination treatment in the human colorectum at 45 days. Started Jun 2024; status: completed.
02
Drugs
omeprazoleaspirin
03
Conditions
Colorectal neoplasia
Beyond the preview
Go deeper on NCT06378398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06378398.